SARS-CoV-2: fear versus data
- PMID: 32201354
- PMCID: PMC7102597
- DOI: 10.1016/j.ijantimicag.2020.105947
SARS-CoV-2: fear versus data
Abstract
SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-CoV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.
Keywords: COVID-19; Coronavirus; SARS-CoV-2.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment in
-
Letter to the Editor regarding the recent contribution by Roussel et al., SARS-CoV-2: Fear versus data.Int J Antimicrob Agents. 2020 Oct;56(4):106074. doi: 10.1016/j.ijantimicag.2020.106074. Epub 2020 Jul 3. Int J Antimicrob Agents. 2020. PMID: 32629113 Free PMC article. No abstract available.
References
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print, 24 February 2020] JAMA. 2020 doi: 10.1001/jama.2020.2648. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
